| Title |
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial
|
|---|---|
| Published in |
The Lancet Haematology, May 2023
|
| DOI | 10.1016/s2352-3026(23)00089-3 |
| Pubmed ID | |
| Authors |
Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W M Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Sibylle Cocciardi, Lars Bullinger, Felicitas Thol, Michael Heuser, Peter Paschka, Verena I Gaidzik, Maral Saadati, Axel Benner, Richard F Schlenk, Konstanze Döhner, Arnold Ganser, German–Austrian AML Study Group, Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W.M. Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammad Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Sibylle Cocciardi, Lars Bullinger, Felicitas Thol, Michael Heuser, Peter Paschka, Verena I. Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Döhner, Arnold Ganser |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 13 | 30% |
| Spain | 4 | 9% |
| Japan | 2 | 5% |
| Romania | 1 | 2% |
| Hong Kong | 1 | 2% |
| Mexico | 1 | 2% |
| Chile | 1 | 2% |
| Brazil | 1 | 2% |
| Lithuania | 1 | 2% |
| Other | 2 | 5% |
| Unknown | 17 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 28 | 64% |
| Scientists | 7 | 16% |
| Practitioners (doctors, other healthcare professionals) | 6 | 14% |
| Science communicators (journalists, bloggers, editors) | 3 | 7% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 61 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 4 | 7% |
| Other | 3 | 5% |
| Researcher | 3 | 5% |
| Professor > Associate Professor | 3 | 5% |
| Student > Doctoral Student | 2 | 3% |
| Other | 9 | 15% |
| Unknown | 37 | 61% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 23% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Arts and Humanities | 1 | 2% |
| Unspecified | 1 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 40 | 66% |